ArticleActa pharmacologica Sinica2026
Vasohibin 1 acts as a key regulator of arrhythmogenesis in pressure-overload-induced cardiac hypertrophy.
Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The morphology and dynamics of microtubules (MTs) are controlled by the posttranslational modification of tubulins and are critical for maintaining cardiac electrophysiological homeostasis. Recent studies have revealed that vasohibin (VASH) is a detyrosinating enzyme of tubulin, and the upregulation of VASH1 (the dominant VASH isoform in the heart) induces MT detyrosination and impaired cardiac function. It remains unknown whether VASH1 participates in the pathogenesis of ventricular arrhythmia, a lethal pathological change in cardiac hypertrophy. Here, we demonstrated that significantly increased expression of VASH1 and detyrosinated α-tubulin led to greater susceptibility of the heart to ventricular arrhythmia, as indicated by an increased number of caffeine and isoproterenol-stimulated premature ventricular complexes (PVCs) on electrocardiography in transverse aortic constriction (TAC)-induced cardiac hypertrophy in mice versus Sham mice. Cardiac-specific VASH1 overexpression induced MT detyrosination and polymerization, increasing the number of stimulated PVCs in normal mice. Optical mapping of the hearts demonstrated that VASH1 overexpression slowed electrical conductance. A mechanistic study revealed that VASH1 upregulation increased the Ca
Indexed as
Identifiers
42693172What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.